D-p-hydroxyphenylglycine

Spezifikationen

22818-40-2CAS-Nummer

245-247-7EG-Nummer

(2R)-2-amino-2-(4-hydroxyphenyl)acetic acidIUPAC-Name

C8H9NO3Chemische Formel

167.16 g/molMolekulargewicht

22818-40-2; D-4-Hydroxyphenylglycine; 4-Hydroxy-D-phenylglycine; (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid; D-(-)-4-Hydroxyphenylglycine; D-P-HYDROXYPHENYLGLYCINE; D-N-(4-Hydroxyphenyl)glycine; (R)-2-(4-HYDROXYPHENYL)GLYCINE; 4-Hydroxyphenylglycine, D-(-)-; (R)-alpha-Amino-4-hydroxybenzeneacetic acid; (2R)-amino(4-hydroxyphenyl)acetic acid; PCM9OIX717; P-hydroxy-(R)-phenylglycine; D-(-)-p-Hydroxyphenylglycine; CHEBI:15695; (R)-(4-HYDROXYPHENYL)GLYCINE; D-(-)-amino(4-hydroxyphenyl)acetic acid; D-2-amino-2-(p-hydroxyphenyl)acetic acid; D-(-)-2-(P-HYDROXYPHENYL)GLYCINE; (R)-Ethyl 2-amino-2-(4-hydroxyphenyl)acetate; (alphaR)-alpha-Amino-4-hydroxybenzeneacetic acid; DTXSID401014840; Benzeneacetic acid, alpha-amino-4-hydroxy-, (alphaR)-; (2R)-2-azaniumyl-2-(4-hydroxyphenyl)acetate; RefChem:524067; DTXCID401473163; 245-247-7; D(-)-4-Hydroxyphenylglycine; H-D-PHG(4-OH)-OH; (R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETIC ACID; MFCD00004262; Benzeneacetic acid, a-amino-4-hydroxy-, (aR)-; p-hydroxy-D-phenylglycine; 4-HYDROXY-D-(-)-2-PHENYLGLYCINE; (2R)-amino(4-hydroxyphenyl)ethanoic acid; L-P-HYDROXYPHENYGLYCINE; UNII-PCM9OIX717; Benzeneacetic acid, .alpha.-amino-4-hydroxy-, (.alpha.R)-; EINECS 245-247-7; d-4-hydroxyphenylglicyne; Cefprozil impurity A CRS; D-4-Hydroxyphenylglycine?; Epitope ID:117718; EC 245-247-7; p-Hydroxyphenyl glycine HCl; SCHEMBL124861; D-?-(4-hydroxyphenyl)glycine; orb1691037; (R)-(4-Hydroxyphenyl)glycine; (R)-2-(4-Hydroxyphenyl)glycine; 4-Hydroxy-D-phenylglycine; D-(-)-2-(4-Hydroxyphenyl)glycine; D-(-)-2-(p-Hydroxyphenyl)glycine; D-4-Hydroxyphenylglycine (Standard); 4-Hydroxy-D-phenylglycine, >=98%; D-(-)-2-(4-Hydroxyphenyl)glycine; EBC-12684; HY-34588R; SBB058359; AKOS006281607; AKOS015924172; D-alpha-(4-hydroxyphenyl)glycine CRS; AC-1085; DB04308; FH01618; (R)--Amino-4-hydroxybenzeneacetic acid; D-.ALPHA.-P-HYDROXYPHENYLGLYCINE; NCGC00164509-02; AS-12542; HY-34588; SY036146; CEFPROZIL IMPURITY A [EP IMPURITY]; CEFADROXIL IMPURITY A [EP IMPURITY]; (|AR)-|A-Amino-4-hydroxybenzeneacetic acid; AMOXICILLIN IMPURITY I [EP IMPURITY]; CS-0020117; GLYCINE, 2-(P-HYDROXYPHENYL)-, D-; H0758; NS00005440; C03493; D71081; EN300-105272; T39811; D-(-)-.ALPHA.-(4-HYDROXYPHENYL)GLYCINE; D-.ALPHA.-AMINO-4-HYDROXYPHENYLACETIC ACID; F222543; F575068; AMOXICILLIN TRIHYDRATE IMPURITY I [EP IMPURITY]; BRD-K30373577-001-01-1; Cefadroxil EP Impurity A(Amoxicillin EP Impurity I); CEFADROXIL MONOHYDRATE IMPURITY A [EP IMPURITY]; CEFPROZIL MONOHYDRATE IMPURITY A [EP IMPURITY]; Q27095129; D-(-)-.ALPHA.-AMINO-4-HYDROXYPHENYLACETIC ACID; D-(-)-4-Hydroxyphenylglycine,4-Hydroxy-D-phenylglycine; Z1198149764; (R)-(-)-2-AMINO-2-(4-HYDROXYPHENYL)ACETIC ACID; (.ALPHA.R)-.ALPHA.-AMINO-4-HYDROXYBENZENEACETIC ACID; (R)-2-Amino-2-(4-hydroxyphenyl)acetic acid, Amoxicillin Impurity; Cefprozil impurity A, European Pharmacopoeia (EP) Reference Standard; Amoxicillin EP Impurity I; Cefprozil EP Impurity A; Cefadroxil EP Impurity A; D-alpha-(4-Hydroxy-phenyl)glycine, European Pharmacopoeia (EP) Reference Standard; GHPSynonyme